Literature DB >> 17103439

A new genomic mechanism leading to cri-du-chat syndrome.

Sarah T South1, Jeffrey J Swensen, Teresa Maxwell, Alan Rope, Arthur R Brothman, Zhong Chen.   

Abstract

Using standard banding techniques, a within-arm intrachromosomal insertion can be mistakenly interpreted as a paracentric inversion. The need to correctly distinguish between these two types of chromosome rearrangements is emphasized by their different reproductive risks. For carriers of an intrachromosomal insertion, the empiric risk of having a liveborn child with a recombinant chromosome leading to a genetic imbalance is at least 15%, whereas the risk for a carrier of a paracentric inversion having a liveborn child with a recombinant chromosome leading to a genetic imbalance is thought to be practically negligible. We report a unique observation in which a paracentric inversion in the short arm of chromosome 5, 46,XX,inv(5)(p13.3p15.3), was identified in a women who had a daughter with an apparently terminal deletion in the distal short arm of chromosome 5, 46,XX,del(5)(p14.3), and the clinical diagnosis of cri-du-chat syndrome. We further characterized the rearrangement, and fluorescence in situ hybridization (FISH) and microsatellite analyses confirmed the paracentric inversion in the mother and showed the deletion in the daughter was maternal in origin. Therefore, this represents a case in which a confirmed paracentric inversion likely resulted in a viable terminal deletion. We propose a mechanism involving dicentric chromosome formation with subsequent breakage and telomere healing during meiosis. This illustrates a new genomic mechanism of chromosome rearrangement leading to cri-du-chat syndrome and should provide significant information for the medical management of patients with other terminal deletion syndromes. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17103439     DOI: 10.1002/ajmg.a.31496

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Large clinically consequential imbalances detected at the breakpoints of apparently balanced and inherited chromosome rearrangements.

Authors:  Sarah T South; Lyndsey Rector; Emily Aston; Leslie Rowe; Samuel P Yang
Journal:  J Mol Diagn       Date:  2010-07-01       Impact factor: 5.568

2.  A de novo chromosomal abnormality in Cri du Chat syndrome.

Authors:  Shunchang C Sun; Fuwei W Luo; Zhiming M Zhou; Yunsheng S Peng; Huiwen W Song
Journal:  Indian J Pediatr       Date:  2013-07-31       Impact factor: 1.967

3.  Mandibulofacial dysostosis in a patient with a de novo 2;17 translocation that disrupts the HOXD gene cluster.

Authors:  David A Stevenson; Steven B Bleyl; Teresa Maxwell; Arthur R Brothman; Sarah T South
Journal:  Am J Med Genet A       Date:  2007-05-15       Impact factor: 2.802

4.  Breakpoint mapping and complete analysis of meiotic segregation patterns in three men heterozygous for paracentric inversions.

Authors:  Samarth Bhatt; Kamran Moradkhani; Kristin Mrasek; Jacques Puechberty; Marina Manvelyan; Friederike Hunstig; Genevieve Lefort; Anja Weise; James Lespinasse; Pierre Sarda; Thomas Liehr; Samir Hamamah; Franck Pellestor
Journal:  Eur J Hum Genet       Date:  2008-08-06       Impact factor: 4.246

5.  Duplication of intrachromosomal insertion segments 4q32→q35 confirmed by comparative genomic hybridization and fluorescent in situ hybridization.

Authors:  Jin Woo Kim; Ju Yeon Park; Ah Rum Oh; Eun Young Choi; Hyun Mee Ryu; Inn Soo Kang; Mi Kyoung Koong; So Yeon Park
Journal:  Clin Exp Reprod Med       Date:  2011-12-31

6.  Mechanisms of telomere loss and their consequences for chromosome instability.

Authors:  Keiko Muraki; Kristine Nyhan; Limei Han; John P Murnane
Journal:  Front Oncol       Date:  2012-10-04       Impact factor: 6.244

7.  The role of ATM in the deficiency in nonhomologous end-joining near telomeres in a human cancer cell line.

Authors:  Keiko Muraki; Limei Han; Douglas Miller; John P Murnane
Journal:  PLoS Genet       Date:  2013-03-28       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.